1. Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway
    Dong-Dong Tian et al, 2017, Oncology Reports CrossRef
  2. Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states
    Hedieh Sattarifard et al, 2023, Biochemistry and Cell Biology CrossRef
  3. Preparation of oridonin nanocrystals and study of their endocytosis and transcytosis behaviours on MDCK polarized epithelial cells
    Huagang Sheng et al, 2020, Pharmaceutical Biology CrossRef
  4. Oridonin inhibits migration, invasion, adhesion and TGF‑β1‑induced epithelial‑mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK‑3β signaling pathway
    Chun‑Yu Li et al, 2017, Oncology Letters CrossRef
  5. New and Emerging Targeted Therapies for Advanced Breast Cancer
    Kristie H. Lau et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Oridonin inhibition and miR-200b-3p/ZEB1 axis in human pancreatic cancer
    Zhifang Gui et al, 2017, International Journal of Oncology CrossRef
  7. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling
    Rong-Xing Liu et al, 2018, International Journal of Oncology CrossRef
  8. PTEN inhibits non‑small cell lung cancer cell growth by promoting G0/G1 arrest and cell apoptosis
    Libao Liu et al, 2018, Oncology Letters CrossRef
  9. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma
    Han Wang et al, 2017, European Journal of Pharmacology CrossRef
  10. The NLRP3 Inflammasome as a Pharmacological Target
    Carlo Marchetti, 2019, Journal of Cardiovascular Pharmacology CrossRef
  11. Oridonin enhances the radiosensitivity of lung cancer cells by upregulating Bax and downregulating Bcl‑2
    Sirui Li et al, 2018, Experimental and Therapeutic Medicine CrossRef
  12. Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
    Barbara Guerra et al, 2019, Pharmaceuticals CrossRef
  13. Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells
    Shusuke Yasuda et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  14. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
    Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef
  15. Plant Extracts and their Secondary Metabolites as Modulators of Kinases
    Muhammad Shoaib Ali Gill et al, 2020, Current Topics in Medicinal Chemistry CrossRef
  16. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
  17. CXCL10-coronated thermosensitive “stealth” liposomes for sequential chemoimmunotherapy in melanoma
    Xiaofei Xin et al, 2023, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
  18. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo
    Mengqiu Song et al, 2018, Molecular Cancer Therapeutics CrossRef
  19. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN
    Wenting Deng et al, 2018, Biomedicine & Pharmacotherapy CrossRef

  20. AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells


    Heqi Bu et al, 2020, OncoTargets and Therapy CrossRef
  21. HDAC8 Prevents Anthrax Lethal Toxin-induced Cell Cycle Arrest through Silencing PTEN in Human Monocytic THP-1 Cells
    Soon-Duck Ha et al, 2017, Toxins CrossRef
  22. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A
    Hong-Chuan Liu et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  23. Revolutionizing Breast Cancer Care: Cutting-Edge Breakthroughs and Future Frontiers in Precision Medicine
    Muhammad Ali Qureshi et al, 2024, Breast Cancer Treatment: An Interdisciplinary Approach CrossRef
  24. Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
    Pavel Spirin et al, 2017, Oncotarget CrossRef
  25. Oridonin enhances γ‑globin expression in erythroid precursors from patients with β‑thalassemia via activation of p38 MAPK signaling
    Lishan Guo et al, 2019, Molecular Medicine Reports CrossRef